TWI901889B - 胱胺的用途 - Google Patents

胱胺的用途

Info

Publication number
TWI901889B
TWI901889B TW111119134A TW111119134A TWI901889B TW I901889 B TWI901889 B TW I901889B TW 111119134 A TW111119134 A TW 111119134A TW 111119134 A TW111119134 A TW 111119134A TW I901889 B TWI901889 B TW I901889B
Authority
TW
Taiwan
Prior art keywords
retinal
cystamine
cells
results
solution
Prior art date
Application number
TW111119134A
Other languages
English (en)
Chinese (zh)
Other versions
TW202312986A (zh
Inventor
山下哲郎
尾拓
Original Assignee
國立大學法人岩手大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立大學法人岩手大學 filed Critical 國立大學法人岩手大學
Publication of TW202312986A publication Critical patent/TW202312986A/zh
Application granted granted Critical
Publication of TWI901889B publication Critical patent/TWI901889B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW111119134A 2021-05-24 2022-05-23 胱胺的用途 TWI901889B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2021086920 2021-05-24
JP2021-086920 2021-05-24
JP2021-172191 2021-10-21
JP2021172191 2021-10-21

Publications (2)

Publication Number Publication Date
TW202312986A TW202312986A (zh) 2023-04-01
TWI901889B true TWI901889B (zh) 2025-10-21

Family

ID=84230063

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111119134A TWI901889B (zh) 2021-05-24 2022-05-23 胱胺的用途

Country Status (3)

Country Link
JP (2) JP7427308B2 (https=)
TW (1) TWI901889B (https=)
WO (1) WO2022249942A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008122032A2 (en) * 2007-04-02 2008-10-09 Benjamin Rubin Treatment method for mmp-implicated pathologies
TW201605434A (zh) * 2013-11-06 2016-02-16 雷普特製藥有限公司 使用半胱胺及其衍生物治療粒腺體疾病

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008122032A2 (en) * 2007-04-02 2008-10-09 Benjamin Rubin Treatment method for mmp-implicated pathologies
TW201605434A (zh) * 2013-11-06 2016-02-16 雷普特製藥有限公司 使用半胱胺及其衍生物治療粒腺體疾病

Also Published As

Publication number Publication date
JP2024032794A (ja) 2024-03-12
JP7427308B2 (ja) 2024-02-05
JPWO2022249942A1 (https=) 2022-12-01
WO2022249942A1 (ja) 2022-12-01
TW202312986A (zh) 2023-04-01

Similar Documents

Publication Publication Date Title
US9138438B2 (en) Method for protecting a retinal neuronal cell
EP3643723B1 (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
UA124698C2 (uk) Офтальмологічний розчин
KR20100016140A (ko) 가령 황반 변성의 예방 또는 치료제
JP7474706B2 (ja) ４－フェニル酪酸を含有する老視の治療または予防剤
JP2021046394A (ja) ブリモニジンとチモロールとを含む、緑内障罹患患者における眼圧を下降させるための組成物
AU2019407391A1 (en) Ursodeoxycholic acid-containing agent for treating or preventing presbyopia
US10973758B2 (en) Methods of eye treatment using therapeutic compositions containing dipyridamole
WO2020145364A1 (ja) 網膜疾患の治療のための眼内または経口投与用医薬組成物
AU2013274582A1 (en) Therapeutic formulation and methods of treatment
TWI901889B (zh) 胱胺的用途
JP2021512847A (ja) キレート剤、浸透促進剤およびヒドロキシエチルセルロースを含む眼科疾患治療用製剤
WO2019024433A1 (zh) 氨基金刚烷胺单硝酸酯类化合物眼用组合物及其制剂和应用
JP7250685B2 (ja) ピリジルアミノ酢酸化合物を含有する医薬
JP2020514347A (ja) チオトロピウムを有効成分として含有する近視予防、近視治療および／または近視進行抑制剤
CN116897046A (zh) 含有熊去氧胆酸或其盐的水性医药组合物
JP2023536938A (ja) ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤
JP7832745B2 (ja) 網膜色素上皮細胞の保護剤
WO2025135087A1 (ja) 慢性移植片対宿主病における眼合併症の予防治療用医薬組成物
US20020077358A1 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
JP6764233B2 (ja) 眼疾患処置薬
HK40107693A (zh) 用於退行性视网膜疾病的trpa1通道拮抗剂化合物
JP2015229671A (ja) 網膜色素上皮細胞保護剤
JP2016153395A (ja) オロット酸含有点眼剤
KR20170095850A (ko) 각막 상피 장애 치료제